Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial-Reference-Cited by-同舟云学术

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

Published:2010-01 Issue:1 Volume:11 Page:38-47
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Folprecht Gunnar,Gruenberger Thomas,Bechstein Wolf O,Raab Hans-Rudolf,Lordick Florian,Hartmann Jörg T,Lang Hauke,Frilling Andrea,Stoehlmacher Jan,Weitz Jürgen,Konopke Ralf,Stroszczynski Christian,Liersch Torsten,Ockert Detlev,Herrmann Thomas,Goekkurt Eray,Parisi Fabio,Köhne Claus-Henning

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging;O'Connell;J Natl Cancer Inst,2004

2. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases;Fong;Ann Surg,1999

3. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie;Nordlinger;Cancer,1996

4. Resection of colorectal liver metastases;Scheele;World J Surg,1995

5. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival;Adam;Ann Surg,2004

Cited by 838 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving patterns of metastatic spread, treatment, and outcome for patients with oligometastatic colorectal cancer;Surgical Oncology Insight;2024-09

2. Comparison of systemic treatments for previously treated patients with unresectable colorectal liver metastases: a systematic review and network meta-analysis;Frontiers in Oncology;2024-07-10

3. The Ugly: Metastatic Colon Cancer—Surgical Options;Clinics in Colon and Rectal Surgery;2024-06-18

4. Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort;Clinical and Translational Oncology;2024-06-04

5. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial;PLOS Medicine;2024-05-10